SAN DIEGO - Gyre Therapeutics (NASDAQ:GYRE), a biotech firm focused on developing treatments for chronic organ diseases, is expected to be included in...
On Tuesday, Piper Sandler showed increased confidence in CytomX Therapeutics (NASDAQ:) stock, upgrading the company's rating from Neutral to Overweight and setting a...